News and Trends 25 Feb 2016High Quality Grade plasmids for a better gene therapy Quality of RNA and viral vectors used in clinical trials is subject to strict regulation. Plasmids that are needed for… February 25, 2016 - 4 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2016French Investor Leads €60M Financial Round for the Future of DNA Synthesis Twist Bioscience is a San Francisco Biotech accelerating science and innovation through rapid, high-quality DNA synthesis piece of tech. And… January 27, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2016New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College London and the University of… January 27, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 20162011-2015: What a Fantastic 5 Years for European Biotech The crisis of 2008 hit the Biotech sector hard, and it wasn't clear how the Biotech industry would get back… January 26, 2016 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2016Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer This multinational Phase III Trial for an Oncolytic Immunotherapy for Advanced Liver Cancer could be what really defines French Transgene as… January 11, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 3 Dec 2015History of Biotech: How the “First” Biotech Patent Generated Millions The Cohen-Boyer patents were now issued 35 years ago at Stanford University… so what were they and how did they… December 3, 2015 - 5 minutesmins - By Marie Godar Share WhatsApp Twitter Linkedin Email
News and Trends 24 Nov 2015Next Generation Sequencing: the final step to massively adopt Personalized Medicine For several decades, physicians have been dreaming of a Personalized Medicine, able to treat patients according to their genetic profile.… November 24, 2015 - 4 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
Sponsored 16 Nov 2015Lentiviral vectors: the secret behind the rise of CAR-T therapies CAR-T has become a hype within the biotech field recently. Companies promising to deliver this new generation of therapies… November 16, 2015 - 5 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 23 Oct 2015Biotech of the week: Genenta Biosciences, a Novel Gene Therapies from Italy This week we depart from East Germany and head south, through both Liechtenstein and Switzerland to the northern region… October 23, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
In Depth 20 Oct 2015The Ultimate Review on how Biotech Changed Cancer Treatment You have roughly 50% chance of developing a cancer in your life and 25% of dying from it. How to… October 20, 2015 - 10 minutesmins - By Jerome Topsent Share WhatsApp Twitter Linkedin Email
News and Trends 16 Oct 2015Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin This week, we're leaving Paris and heading East to a city that's 9 times bigger than the capital of France, it's… October 16, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2015Nobel Prize in Chemistry 2015: DNA Repairing Mechanisms that Keep you Alive DNA repair mechanisms are crucial to our existence. Without them, we would not survive because of DNA damage caused by… October 7, 2015 - 4 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2015€31M goes to a 15-month old Start-up tackling the leading cause of Dwarfism TherAchon is a 15-month old start-up from the Nice area (France) which has attracted some serious US investors as of… October 5, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 28 Aug 2015FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market? The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants to sell it in the… August 28, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 22 Aug 2015What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer… Welcome in our Top of the week list! This week is full of uncommon stories. Did you know that we… August 22, 2015 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2015DNA to play an essential role in the future of Computers? You can do terrific things with DNA - convicting a murderer, confirming the right father ... and building computers! As… August 20, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 19 Aug 2015Top 5 Biotech Books to Enjoy your Summer on the Beach Summer is a great time to read books and get inspired for the year to come. Here's a Top 5 list… August 19, 2015 - 3 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 12 Aug 2015A Tale of Love for UniQure and Bristol-Myers Squibb In May, Bristol-Myers Squibb (BMS) nailed down the exclusive access to uniQure's gene therapy platform to treat cardiovascular diseases. Everything… August 12, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 4 Aug 2015How Gene Therapy could Cure Deafness Cochlear implants achieved a great success in the past. However, there is hope that patients suffering from hearing loss won't… August 4, 2015 - 4 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2015Theravectys’ HIV Cure on the Road to Success Theravectys just announced positive results of its HIV drug candidate in a phase I/II study. The therapeutic vaccine using lentivirus could be… July 20, 2015 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email